The first Hungarian patient with Guillain-Barre syndrome after COVID-19
Guillain-Barré syndrome (GBS) is a sporadic, relatively rare disease. In serious cases, it can lead to respiratory failure and death. The correlation between SARS-CoV-2 and the risk of GBS is not yet known. COVID-19-associated prolonged pulmonary complications could be worsened by the potential airway interference caused by GBS. The literature is inconsistent whether SARS-CoV-2 virus has direct or indirect effect on the onset of GBS. The authors describe the medical history of the first published GBS patient in Hungary with a preceding confirmed COVID-19 infection. The trigger role of COVID-19 infection is assumed because of the subsequent development of GBS after COVID-19 infection. So far none of the patients in the literature (including this patient) had positive PCR of SARS-CoV-2 virus from the cerebrospinal fluid.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
Ideggyogyaszati szemle - 74(2021), 1-2 vom: 30. Jan., Seite 64-66 |
| Sprache: |
Ungarisch |
|---|
| Weiterer Titel: |
Covid-19-asszociált Guillain–Barré-szindróma elsô hazai esete |
|---|
| Beteiligte Personen: |
Al-Muhanna, Nadim [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case Reports |
|---|
| Anmerkungen: |
Date Completed 29.01.2021 Date Revised 29.01.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.18071/isz.74.0064 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320590038 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320590038 | ||
| 003 | DE-627 | ||
| 005 | 20231225173915.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||hun c | ||
| 024 | 7 | |a 10.18071/isz.74.0064 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1068.xml |
| 035 | |a (DE-627)NLM320590038 | ||
| 035 | |a (NLM)33497053 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a hun | ||
| 100 | 1 | |a Al-Muhanna, Nadim |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The first Hungarian patient with Guillain-Barre syndrome after COVID-19 |
| 246 | 3 | 3 | |a Covid-19-asszociált Guillain–Barré-szindróma elsô hazai esete |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.01.2021 | ||
| 500 | |a Date Revised 29.01.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Guillain-Barré syndrome (GBS) is a sporadic, relatively rare disease. In serious cases, it can lead to respiratory failure and death. The correlation between SARS-CoV-2 and the risk of GBS is not yet known. COVID-19-associated prolonged pulmonary complications could be worsened by the potential airway interference caused by GBS. The literature is inconsistent whether SARS-CoV-2 virus has direct or indirect effect on the onset of GBS. The authors describe the medical history of the first published GBS patient in Hungary with a preceding confirmed COVID-19 infection. The trigger role of COVID-19 infection is assumed because of the subsequent development of GBS after COVID-19 infection. So far none of the patients in the literature (including this patient) had positive PCR of SARS-CoV-2 virus from the cerebrospinal fluid | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Guillain-Barré syndrome | |
| 650 | 4 | |a SARS-CoV-2 (COVID-19 virus) infection | |
| 700 | 1 | |a Béres-Molnár, Anna Katalin |e verfasserin |4 aut | |
| 700 | 1 | |a Jarecsny, Tamás |e verfasserin |4 aut | |
| 700 | 1 | |a Folyovich, András |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ideggyogyaszati szemle |d 1954 |g 74(2021), 1-2 vom: 30. Jan., Seite 64-66 |w (DE-627)NLM119915138 |x 0019-1442 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2021 |g number:1-2 |g day:30 |g month:01 |g pages:64-66 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18071/isz.74.0064 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2021 |e 1-2 |b 30 |c 01 |h 64-66 | ||